Originally published as JCO Early Release 10.1200/JCO.2005.04.0063 on October 31 2005

This Article Full Text Full Text (PDF) Publisher's Note Journal of Oncology Practice Summary Erratum (v24,p1224) Erratum (v24,p1224) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Desch, C. E. Search for Related Content PubMed PubMed Citation Articles by Desch, C. E. Pubmed/NCBI databases Medline Plus Health Information Colorectal Cancer Social Bookmarking                            What's this?

Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice Guideline

From the American Society of Clinical Oncology, Alexandria, VA

Address reprint requests to Mark R. Somerfield, American Society of Clinical Oncology, 1900 Duke St, Suite 200, Alexandria, VA 22314; e-mail: guidelines{at}asco.org

PURPOSE: To update the 2000 American Society of Clinical Oncology guideline on colorectal cancer surveillance.

RECOMMENDATIONS: Based on results from three independently reported meta-analyses of randomized controlled trials that compared low-intensity and high-intensity programs of colorectal cancer surveillance, and on recent analyses of data from major clinical trials in colon and rectal cancer, the Panel recommends annual computed tomography (CT) of the chest and abdomen for 3 years after primary therapy for patients who are at higher risk of recurrence and who could be candidates for curative-intent surgery; pelvic CT scan for rectal cancer surveillance, especially for patients with several poor prognostic factors, including those who have not been treated with radiation; colonoscopy at 3 years after operative treatment, and, if results are normal, every 5 years thereafter; flexible proctosigmoidoscopy every 6 months for 5 years for rectal cancer patients who have not been treated with pelvic radiation; history and physical examination every 3 to 6 months for the first 3 years, every 6 months during years 4 and 5, and subsequently at the discretion of the physician; and carcinoembryonic antigen every 3 months postoperatively for at least 3 years after diagnosis, if the patient is a candidate for surgery or systemic therapy. Chest x-rays, CBCs, and liver function tests are not recommended, and molecular or cellular markers should not influence the surveillance strategy based on available evidence.

Approved by the Board on August 9, 2005.

Authors' disclosures of potential conflicts of interest are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. S. Park, H. K. Kim, Y. S. Choi, K. Kim, Y. M. Shim, J. Jo, W.-Y. Lee, H.-K. Chun, Y. S. Park, W. K. Kang, et al. Outcomes after repeated resection for recurrent pulmonary metastases from colorectal cancer Ann. Onc., October 27, 2009; (2009) mdp475v1. [Abstract] [Full Text] [PDF]

				V. L. Tsikitis, K. Malireddy, E. A. Green, B. Christensen, R. Whelan, J. Hyder, P. Marcello, S. Larach, D. Lauter, D. J. Sargent, et al. Postoperative Surveillance Recommendations for Early Stage Colon Cancer Based on Results From the Clinical Outcomes of Surgical Therapy Trial J. Clin. Oncol., August 1, 2009; 27(22): 3671 - 3676. [Abstract] [Full Text] [PDF]

				M. E. Del Giudice, E. Grunfeld, B. J. Harvey, E. Piliotis, and S. Verma Primary Care Physicians' Views of Routine Follow-Up Care of Cancer Survivors J. Clin. Oncol., July 10, 2009; 27(20): 3338 - 3345. [Abstract] [Full Text] [PDF]

				E. Van Cutsem, J. Oliveira, and On behalf of the ESMO Guidelines Working Group Primary colon cancer: ESMO Clinical Recommendations for diagnosis, adjuvant treatment and follow-up Ann. Onc., May 1, 2009; 20(suppl_4): iv49 - iv50. [Full Text] [PDF]

				K. A. Miles, B. Ganeshan, M. R. Griffiths, R. C. D. Young, and C. R. Chatwin Colorectal Cancer: Texture Analysis of Portal Phase Hepatic CT Images as a Potential Marker of Survival Radiology, February 1, 2009; 250(2): 444 - 452. [Abstract] [Full Text] [PDF]

				C. M. Sturgeon, M. J. Duffy, U.-H. Stenman, H. Lilja, N. Brunner, D. W. Chan, R. Babaian, R. C. Bast Jr., B. Dowell, F. J. Esteva, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers Clin. Chem., December 1, 2008; 54(12): e11 - e79. [Abstract] [Full Text] [PDF]

				H. J. Murff, N. B. Peterson, J. H. Fowke, M. Hargreaves, L. B. Signorello, R. S. Dittus, W. Zheng, and W. J. Blot Colonoscopy Screening in African Americans and Whites With Affected First-Degree Relatives Arch Intern Med, March 24, 2008; 168(6): 625 - 631. [Abstract] [Full Text] [PDF]

				C. F. Snyder, C. C. Earle, R. J. Herbert, B. A. Neville, A. L. Blackford, and K. D. Frick Preventive Care for Colorectal Cancer Survivors: A 5-Year Longitudinal Study J. Clin. Oncol., March 1, 2008; 26(7): 1073 - 1079. [Abstract] [Full Text] [PDF]

				P. M. Lynch New Issues in Genetic Counseling of Hereditary Colon Cancer Clin. Cancer Res., November 15, 2007; 13(22): 6857s - 6861s. [Abstract] [Full Text] [PDF]

				A. Sezeur, F.P. Chatelet, Ch. Cywiner, Cl. de Labriolle-Vaylet, C. Chastang, Cl. Billotey, M. Malafosse, D. Gallot, P. Betton, F. Montravers, et al. Pathology Underrates Colon Cancer Extranodal and Nodal Metastases; Ex vivo Radioimmunodetection Helps Staging Clin. Cancer Res., September 15, 2007; 13(18): 5592s - 5597s. [Abstract] [Full Text] [PDF]

				Y. J. Choi, S. H. Park, S. S. Lee, E. K. Choi, C. S. Yu, H. C. Kim, and J. C. Kim CT Colonography for Follow-Up After Surgery for Colorectal Cancer Am. J. Roentgenol., August 1, 2007; 189(2): 283 - 289. [Abstract] [Full Text] [PDF]

				A. B. Benson III The Hope for Today--The Promise for Tomorrow: Will Oncologists Meet the Challenge? J. Clin. Oncol., June 1, 2007; 25(16): 2156 - 2158. [Full Text] [PDF]

				A. Gillams Minimally invasive treatment for liver and lung metastases in colorectal cancer BMJ, May 19, 2007; 334(7602): 1056 - 1057. [Full Text] [PDF]

				E. Flamini, L. Mercatali, O. Nanni, D. Calistri, R. Nunziatini, W. Zoli, P. Rosetti, N. Gardini, A. Lattuneddu, G. M. Verdecchia, et al. Free DNA and Carcinoembryonic Antigen Serum Levels: An Important Combination for Diagnosis of Colorectal Cancer Clin. Cancer Res., December 1, 2006; 12(23): 6985 - 6988. [Abstract] [Full Text] [PDF]

				C. C. Earle Failing to Plan Is Planning to Fail: Improving the Quality of Care With Survivorship Care Plans J. Clin. Oncol., November 10, 2006; 24(32): 5112 - 5116. [Abstract] [Full Text] [PDF]

				B. N. Polite, J. J. Dignam, and O. I. Olopade Colorectal Cancer Model of Health Disparities: Understanding Mortality Differences in Minority Populations J. Clin. Oncol., May 10, 2006; 24(14): 2179 - 2187. [Abstract] [Full Text] [PDF]